Pession, Andrea <br/><br/>
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Oct 2005 
 - 7161-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2005.11.411  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Age Factors<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Asparaginase--administration & dosage<br/>Child<br/>Child, Preschool<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infant<br/>Male<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Treatment Outcome